Kaleido · 1 month ago
Regulatory Affairs Manager (US)
ViCentra is on a mission to redefine diabetes care through technological innovation and human-centered design. As the Regulatory Affairs Manager (US), you will build and own the U.S. regulatory framework, preparing FDA submissions and ensuring compliance for market access.
Health CareMedicalMedical Device
Responsibilities
Develop and execute U.S. regulatory strategies to support product clearance and lifecycle management
Prepare, submit, and maintain FDA filings (e.g., 510(k), device listings, establishment registration)
Act as primary liaison with the FDA, including participation in meetings and responding to questions post-submission
Set up and manage U.S. post-market systems: complaints, vigilance, MDR, recalls, and surveillance
Integrate regulatory requirements into our Quality Management System (Egnyte/ETQ)
Monitor evolving FDA regulations and translate them into actionable guidance
Collaborate with cross-functional teams (Quality, Engineering, Clinical) to ensure compliance and readiness for scale
Qualification
Required
Bachelor's degree in Quality, Biomedical Engineering, Health Sciences, or related field
Solid knowledge of U.S. medical device regulations (FDA 21 CFR Parts 803, 807, 820) and ISO 13485
Hands-on experience with 510(k) submissions and U.S. regulatory processes
Ability to work independently in a fast-moving, scale-up environment—comfortable with ambiguity and building from scratch
Excellent communication skills and a proactive, problem-solving mindset
Preferred
Start-up or scale-up experience
Experience with diabetes-related products
Familiarity with risk management tools (FMEA)
Company
Kaleido
ViCentra BV, Medical Devices, Utrecht Founded in 2013 in Utrecht, The Netherlands, ViCentra is a leading early stage commercial company focused on the development, manufacturing and commercialisation of the Kaleido insulin pump designed to help people with diabetes live life on their own terms.
Funding
Current Stage
Late StageTotal Funding
$193.9MKey Investors
Innovation IndustriesPartners in EquityInvest-NL
2026-01-08Series D· $13M
2025-09-03Series D· $85M
2021-12-16Series C· $73.67M
Recent News
BioWorld Financial Watch
2026-01-11
Med-Tech Insights
2026-01-09
Medical Device Network
2026-01-09
Company data provided by crunchbase